ABOLIGO LIMITED
Significant control: Nicholas James Hutchings (25–50%), Brian Kishore Carpenter (25–50%) and 1 more
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Aboligo Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Aboligo Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ABOLIGO LIMITED is an active private limited company (company number 15752547) incorporated on 31 May 2024, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 May 2026, showing net assets of £1.30m and cash of £1.24m, with 5 employees on average. Net assets rose 1779% on the prior period (£69k).
By net assets it sits in the top quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
Ownership and control
- Dr Nicholas James Hutchings
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr Brian Kishore Carpenter
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr Nicolas Steven Gee
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 31 May 20242 yrs ago
- Next accounts due
- 29 February 2028in 491 days
- Confirmation statement due
- 14 June 2027in 231 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2026 | £1.30m | £1.24m | £66k | — | — | — | 5 |
| 31 May 2025 | £69k | £40k | £42k | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £1,303,881 at 31 May 2026
- Net assets up 10% or more on the prior period+1778.8% vs prior period
- Cash at bank of £50,000 or moreCash £1,240,533
- Incorporated two to five years agoIncorporated 31 May 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 491 days
- Confirmation statement duein 231 days
- Accounts period endNet assets £1.30m · small accounts
- Accounts period endNet assets £69k · small accounts
- Incorporated
Similar companies in Cambridge
- CIDER BIO LIMITEDCambridge · inc. May 2024
- C BIOLOGICS NEWCO LIMITEDCambridge · inc. May 2024
- C BIOLOGICS HOLDCO LIMITEDCambridge · inc. May 2024
- KLURA LABS LIMITEDHaverhill · inc. Jun 2024
- QUILT BIO LIMITEDCambridge · inc. Jun 2024
- FIG THERAPEUTICS LIMITEDCambridge · inc. Apr 2024
All companies incorporated on 31 May 2024 · in May 2024.
Reminders for ABOLIGO LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.